Clinical Trial

« Back to List

BRE 186

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: December 31, 2012

Research Hotline: 803-461-3708

Details: Phase 2 Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy. 

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share